Sanofi injects €170m in France to make flu vaccine
Sanofi has invested €170m ($201m) in a facility in France to expand supply of its quadrivalent influenza vaccine, VaxigripTetra.
Sanofi has invested €170m ($201m) in a facility in France to expand supply of its quadrivalent influenza vaccine, VaxigripTetra.
Hitachi Chemical is expanding manufacturing and cleanroom capacity at its cell therapy-focused CDMO site in Allendale, New Jersey, US.
The world’s largest single bioproduction plant has received its first US regulatory approval to make a monoclonal antibody, says CDMO Samsung Biologics.